Immatics N.V.
IMTXImmatics N.V. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Harpreet Singh, with a market cap of $1.2B.
$1.18B+45.3%
We’re still putting together Immatics N.V.’s detailed financials. Its latest earnings are below. You’ll find its full filings on SEC EDGAR, or explore the companies we cover.
Ask us to move Immatics N.V. up the queue, and we’ll analyze its filings next.
Earnings
Next report
Aug 12, 2026 (In 2 weeks)Revenue estimate$11.7M
EPS estimate-$0.48
Profile
CountryGermany
Listed2020
Employees343.0
CEOHarpreet Singh
SectorHealthcare
IndustryBiotechnology
Websiteimmatics.com
FilingsSEC EDGAR